跳至主要内容
临床试验/NCT04729556
NCT04729556已完成不适用

Safety Evaluation of a Film-forming Cream Containing Sericin and Chitosan for Pressure Sore Treatment in Healthy Volunteers

Chulalongkorn University1 个研究点 分布在 1 个国家目标入组 112 人开始时间: 2020年2月15日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
112
试验地点
1
主要终点
Skin erythema index

研究概览

简要总结

A prospective, randomized, active-controlled clinical trial was conducted to evaluate safety of sericin-chitosan cream in healthy volunteers.

详细描述

A prospective, randomized, active-controlled clinical trial was conducted to initially evaluate safety of sericin-chitosan cream in comparison with a commercially available cream containing dimethicone for pressure sore treatment in healthy volunteers. The results of this study provided preliminary safety profile of sericin-chitosan cream before conducting the further clinical trial in specific population (pateints with early-stage pressure sore).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
20 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者
是

入选标准

  • •Healthy volunteers at the age of 20 - 65 years
  • •voluntarily sign inform consent

排除标准

  • •Diagnosed with chronic skin conditions (e g. eczema and psoriasis) and immunocompromised diseases
  • •Allergic to silk sericin and chitosan, and dimethicone
  • •Received immunosuppressive therapy, antihistamine, and corticosteroid drugs two weeks before study enrollment.

研究组 & 干预措施

Sericin and chitosan cream

Experimental

A flim-forming cream containing sericin and chitosan cream. Apply sericin and chitosan cream on the back area of healthy volunteers and cover with self-adhesive nonwoven fabric in induction phase I (72 hours), induction phase II (72 hours), and challenge phase (72 hours).

干预措施: Sericin and chitosan cream (Device)

Cavilon

Active Comparator

Active control is a commercial cream containing dimethicone as the substance forms a durable, thin, and transparent film. The cream is used as a moisturizer to prevent the skin against irritation, dryness, and pressure ulcers.

Apply sericin and chitosan cream on the back area of healthy volunteers and cover with self-adhesive nonwoven fabric in induction phase I (72 hours), induction phase II (72 hours), and challenge phase (72 hours).

干预措施: Sericin and chitosan cream (Device)

结局指标

主要结局

Skin erythema index

时间窗: 17 days

Erythema index will be measured using Cutometer (Mexameter). There is no unit. Higher value mean higher risk of post inflammatory reaction.

Skin melanin index

时间窗: 17 days

Melanin index will be measured using Cutometer (Mexameter). There is no unit. Higher value mean higher risk of post inflammatory reaction.

次要结局

  • Visual skin irritation(17 days)
  • Self-report topical side effects: rash, edema, vesicles, and itching(17 days)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Pornanong Aramwit, Pharm.D., Ph.D

Professor

Chulalongkorn University

研究点 (1)

Loading locations...

相似试验